How much is Telis Bioscience worth in 2026?

Telis Bioscience has a current valuation of N/A based on their Early Stage VC (Series A1) round and secondary market data.

How much funding has Telis Bioscience raised?

Telis Bioscience has raised N/A in total funding across 1 funding rounds.

Telis Bioscience

Drug Discovery

Telis Bioscience valuation and funding history | Last updated: April 1, 2020 | 1 funding rounds

Current Valuation

N/A

As of April 1, 2020

Total Funding Raised

N/A

Across 1 round

Last Round

Early Stage VC (Series A1)

$2.1M

Last Funding

Apr 2020

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
April 1, 2020	Early Stage VC (Series A1)	$2.1M	N/A	-

Valuation Analysis

Current Valuation Metrics

Telis Bioscience is currently valued at N/A as of April 1, 2020.

Track Telis Bioscience Valuation Updates

Get notified when Telis Bioscience raises new funding or valuation changes

Explore More Data

Detailed analysis for Telis Bioscience

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Telis Bioscience's valuation history, funding rounds, and growth metrics.

No credit card required

What is Telis Bioscience Worth in 2026?

Telis Bioscience is a leading private company in the Drug Discovery sector. Track Telis Bioscience's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Telis Bioscience Valuation is Determined

Private company valuations like Telis Bioscience's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.